SCHEMBL7493802

SCHEMBL7493802

CSc1ccc(Cl)cc1C(=O)CBr

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GSK3B P49841 1/20 0.46
▸ ADRA1D P25100 1/20 0.42
▸ ADRA1A P35348 1/20 0.42
▸ ADRA1B P35368 1/20 0.42
▸ HTT P42858 4/20 0.40
▸ HPGD P15428 2/20 0.40
▸ ALDH1A1 P00352 5/20 0.39
▸ MAPK1 P28482 2/20 0.39
▸ HIF1A Q16665 1/20 0.39
▸ ERCC5 P28715 1/20 0.38
▸ FEN1 P39748 1/20 0.38
▸ CCR2 P41597 2/20 0.38
▸ GAA P10253 2/20 0.38
▸ TP53 P04637 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ LMNA P02545 3/20 0.37
▸ MEN1 O00255 3/20 0.37
▸ KMT2A Q03164 3/20 0.37
▸ MAPT P10636 4/20 0.37
▸ KDM4E B2RXH2 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12164877 0.85 ADRA1D (0.43) ADRA1DADRA1AADRA1BHTTHPGD
Hydrochloric Acid SCHEMBL7497463 0.82 ADRA1D (0.47) ADRA1DADRA1AADRA1BHTTHPGD
SCHEMBL7493689 0.81 GSK3B (0.44) GSK3BHTTHPGDALDH1A1GAA
SCHEMBL7493280 0.80 PTPN1 (0.46) GSK3BLMNAMEN1KMT2AMAPT
SCHEMBL20053804 0.79 ALDH1A1 (0.57) ADRA1DADRA1AADRA1BHTTHPGD
SCHEMBL7492153 0.79 HTT (0.44) ADRA1DADRA1AADRA1BHTTHPGD
SCHEMBL12505458 0.77 KDM4E (0.54) ADRA1DADRA1AADRA1BHTTHPGD
SCHEMBL3922315 0.77 GSK3B (0.50) GSK3BHTTHPGDALDH1A1MAPK1
SCHEMBL29391618 0.77 ERCC5 (0.61) GSK3BHPGDALDH1A1MAPK1HIF1A
SCHEMBL404490 0.77 ERCC5 (0.61) GSK3BHPGDALDH1A1MAPK1HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1100803-B1 PYRROLO [2,1-B] [1,3]BENZOTHIAZEPINES WITH ATYPICAL ANTIPSYCHOTIC ACTIVITY SIGMA TAU IND FARMACEUTI (IT) 2002-10-02 — — EP disclosed
US-6391870-B2 DOPAMINERGIC AGENT SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2002-05-21 — — US disclosed
US-20020006921-A1 Pyrrolo {2,1-b}{1,3}benzothiazepines with atypical antipsychotic activity SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2002-01-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020006921-A1 Pyrrolo {2,1-b}{1,3}benzothiazepines with atypical antipsychotic activity GABRE, GRIN2B, DRD1 GSK3B 3347/4885ADRA1D 249/4885ADRA1A 525/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback